MDI

D1_048789

Catching up with July

Well as I expected, lots has been happening in the diabetes tech world while I’ve been away working on the African photographic expedition. So this post is a little bit of a catch-up. Ryzodeg At the start of August the Australian PBS was updated to include Novo’s Ryzodeg insulin. Although Novo’s long-acting Tresiba is not …

Catching up with JulyRead More »

Another “new” insulin for Australia

In April there was big news as Sanofi’s long-acting Toujeo U300 insulin was added to the Pharmaceutical Benefits Scheme (PBS) and thus became accessible to many people. It had received TGA approval some time beforehand and was available under private prescription, but the cost was significant.┬áBut at the time I failed to mention another new …

Another “new” insulin for AustraliaRead More »

Backup insulin pens

For a change I’m not going to write here about the latest insulin pumps, CGMs, and closed-loop systems. This is about insulin pens, and possible compatibility between some models that the manufacturers won’t tell you about. Before I started using an insulin pump, I used injection pens for both my short-acting (“bolus”) insulin and my …

Backup insulin pensRead More »